Daniel P. van Plew, EVP & General Mgr, Industrial at REGENERON PHARMACEUTICALS, INC. (REGN), sold 44,624 shares at $722.83 ($32.5M) on 2022-09-12, disclosed to the SEC on 2022-09-13.
Open-market sale of $32.5M REGN by EVP & General Mgr, Industrial. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $730.96 | 35,304 | $25.8M | 79.4% |
| 2 | $709.93 | 87 | $62K | 0.2% |
| 3 | $709.93 | 87 | $62K | 0.2% |
| 4 | $710.25 | 2 | $1K | 0.0% |
| 5 | $711.85 | 70 | $50K | 0.2% |
| 6 | $712.44 | 110 |
| $78K |
| 0.2% |
| 7 | $712.44 | 110 | $78K | 0.2% |
| 8 | $713.67 | 572 | $408K | 1.3% |
| 9 | $713.67 | 572 | $408K | 1.3% |
| 10 | $714.42 | 267 | $191K | 0.6% |
| 11 | $714.42 | 267 | $191K | 0.6% |
| 12 | $715.39 | 861 | $616K | 1.9% |
| 13 | $715.39 | 861 | $616K | 1.9% |
| 14 | $716.28 | 1,052 | $754K | 2.3% |
| 15 | $716.28 | 1,052 | $754K | 2.3% |
| 16 | $717.59 | 647 | $464K | 1.4% |
| 17 | $717.59 | 647 | $464K | 1.4% |
| 18 | $718.50 | 435 | $313K | 1.0% |
| 19 | $718.50 | 435 | $313K | 1.0% |
| 20 | $719.72 | 159 | $114K | 0.4% |
| 21 | $719.72 | 159 | $114K | 0.4% |
| 22 | $720.41 | 181 | $130K | 0.4% |
| 23 | $720.41 | 181 | $130K | 0.4% |
| 24 | $721.38 | 174 | $126K | 0.4% |
| 25 | $721.38 | 174 | $126K | 0.4% |
| 26 | $722.83 | 79 | $57K | 0.2% |
| 27 | $722.83 | 79 | $57K | 0.2% |
| Total | $727.92 avg | 44,624 | $32.5M | 100% |
| Filing → |
| REGN | SELL | 2022-11-25 | $17.7M | — | Filing → |
| REGN | SELL | 2022-11-08 | $10.9M | — | Filing → |
| REGN | SELL | 2022-02-24 | $6.4M | — | Filing → |